Sage Therapeutics Inc. (SAGE)
NASDAQ: SAGE
· Real-Time Price · USD
8.68
0.00 (0.00%)
At close: Jul 30, 2025, 3:59 PM
Sage Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -49.65M | -62.21M | -95.78M | -93.55M | -102.85M | -108.48M | -32.71M | -201.63M | -160.32M | -146.83M | -147.15M | -137.32M | -126.26M | -122.06M | -124.71M | -130.17M | -107.25M | -95.76M |
Depreciation & Amortization | -442K | -981K | 129K | 255K | 311K | 336K | 409K | 330K | 331K | 323K | 290K | 278K | 279K | 275K | 333K | 374K | 893K | 2.58M |
Stock-Based Compensation | 8.73M | 6.93M | 9.43M | 14.21M | 17.17M | 13.7M | 12.95M | 28.69M | 11.69M | 20.04M | 15.24M | 13.17M | 14.64M | 18.55M | 20.65M | 34.34M | 27.66M | 21.98M |
Other Working Capital | 18.17M | -18.17M | 9.45M | 5.27M | 4.25M | -10.47M | -105.47M | 39.8M | 24.23M | 6.55M | -5.75M | 2.08M | 4.56M | -3.67M | 108K | 23.7M | -19.66M | -29.34M |
Other Non-Cash Items | -42.76M | -25K | -1.1M | -2.1M | 13M | -55.87M | 6.12M | -4.95M | -4.43M | -3.21M | -1.36M | 1.06M | 2.32M | 2.34M | 475K | 1.11M | -4.05M | -8.13M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 25.43M | -25.43M | 20.76M | -1.18M | 6.99M | 58.19M | -106.29M | 41.69M | 21.22M | -24.01M | 6.04M | 3.95M | 2.59M | -6.92M | 5.75M | 25.51M | -20.03M | -29.75M |
Operating Cash Flow | -58.69M | -81.73M | -66.56M | -82.36M | -80.44M | -37.83M | -119.52M | -135.87M | -131.52M | -153.68M | -126.93M | -118.86M | -106.44M | -107.8M | -97.5M | -68.83M | -102.77M | -109.09M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | 112K | -328K | -112K | -225K | -282K | -364K | -122K | -169K | -372K | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -41.95M | -160.72M | -45.7M | -195.09M | -90.06M | -111.32M | -134.38M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -68.6M | -87.97M | -88.7M | -102.32M | -198.32M | -61.62M | -134.96M | -70.06M | -232.76M | -156.89M | -198.53M | -251.4M | -129.18M | -301.93M | -318.75M | -363.26M | -466.36M | -841.79M |
Sales Maturities Of Investments | 149.62M | 133.76M | 135.28M | 183.37M | 197.93M | 201.05M | 176.91M | 230.78M | 278.47M | 351.98M | 288.59M | 362.72M | 263.56M | 292.54M | 288.86M | 338.27M | 177.97M | 182.97M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | -386K | 139.44M | 41.95M | 160.72M | 45.7M | 195.09M | 90.06M | 111.32M | 134.38M | -9.39M | -29.89M | -24.98M | -288.39M | -658.82M |
Investing Cash Flow | 81.02M | 45.78M | 46.57M | 81.05M | -386K | 139.44M | 42.06M | 160.39M | 45.59M | 194.87M | 89.78M | 110.95M | 134.26M | -9.56M | -30.26M | -24.98M | -288.39M | -658.82M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | 3K | -1K | -2K | -262K | -4K | -8K | -629K | -4K | -15K | -24K | n/a | -589K | n/a | -796K | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -65K | 148K | -2K | 1.04M | 8.07M | 1.56M | -262K | 2.77M | 847K | 2.67M | 29K | 1.23M | 13K | 1.8M | -170K | 1.82M | 6.07M | 5.62M |
Financial Cash Flow | -65K | 148K | -2K | 1.04M | 8.07M | 1.56M | -262K | 2.77M | 847K | 2.67M | 29K | 1.23M | 13K | 1.8M | -170K | 1.82M | 6.07M | 5.62M |
Net Cash Flow | 22.26M | -35.8M | -19.99M | 1.23M | -72.75M | 101.66M | -77.72M | 27.3M | -85.08M | 43.86M | -37.13M | -6.68M | 27.84M | -115.56M | -127.93M | -91.99M | -385.09M | -762.28M |
Free Cash Flow | -58.69M | -81.73M | -66.56M | -82.36M | -80.44M | -37.83M | -119.41M | -136.19M | -131.63M | -153.91M | -127.21M | -119.23M | -106.56M | -107.97M | -97.87M | -68.83M | -102.77M | -109.09M |